共 50 条
- [43] A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis [J]. REUMATOLOGIA CLINICA, 2021, 17 (09): : 536 - 542
- [50] Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysis [J]. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (06): : 764 - 771